Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2007
11/14/2007EP1854885A2 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/14/2007EP1854881A1 METHODS OF IDENTIFYING PURKINJE CELLS USING THE Corl2 GENE AS A TARGET
11/14/2007EP1854808A2 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
11/14/2007EP1854481A2 Cerebral stroke/cerebral edema preventive or remedy containing IL-8 binding inhibitor as active ingredient
11/14/2007EP1854471A1 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
11/14/2007EP1853716A2 Process and genes for expression and over-expression of active ýfefe¨hydrogenases
11/14/2007EP1853623A1 Animal product free system and process for purifying a botulinum toxin
11/14/2007EP1853622A1 Media for clostridium bacterium and processes for obtaining a clostridial toxin
11/14/2007EP1853309A2 Bispecific binding agents for modulating biological activity
11/14/2007EP1716225B1 Method for the production of recombined proteins in eukaryontic host cells
11/14/2007EP1411064B1 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
11/14/2007EP1373503B1 Neurotrophic factors
11/14/2007EP1354034B1 Transgenic transchromosomal rodents for making human antibodies
11/14/2007EP1210462B1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications
11/14/2007EP1121454B1 Extracellular novel rage binding protein (en-rage) and uses thereof
11/14/2007EP1117435B1 Mutant cholera holotoxin as an adjuvant
11/14/2007EP1092017B1 Novel gaba-b receptor
11/14/2007EP1007718B1 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying
11/14/2007EP1003783B1 Lipoprotein-regulating medicaments
11/14/2007EP0756628B1 Morphogenic protein-specific cell surface receptors and uses therefor
11/14/2007CN101070344A G-csf receptor agonist antibodies and screening method therefor
11/14/2007CN100348730C Method for preparing medical collagen protein powder
11/14/2007CN100348729C Method for preparing plant peptone
11/13/2007US7294753 Method for preparing anti-MIF antibodies
11/13/2007US7294710 High-affinity choline transporter
11/13/2007US7294708 Telomerase reverse transcriptase fragments and uses thereof
11/13/2007US7294705 Anti-PRO3580 antibodies
11/13/2007US7294703 Vectors with DNA encoding pro polypeptides
11/13/2007US7294702 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/13/2007US7294700 Anti-PRO846 antibodies
11/13/2007US7294699 Factor vii or factor ix polypeptides; enhanced membrane binding; blood disorders; blood coagulation
11/13/2007US7294698 An isolated Archipelin polypeptide
11/13/2007US7294696 Native receptor or membrane-bound proteins
11/13/2007US7294695 Stimulate an immune response and induce inflammation by inducing mononuclear cell, eosinophil and PMN infiltration at the site of injection of the animal
11/13/2007US7294693 Pro4428 Polypeptides
11/13/2007US7294692 Vectors with DNA encoding pro polypeptides
11/13/2007US7294691 Soluble secreted α2δ-2calcium channel subunit polypeptide
11/13/2007US7294509 Pre-adipose cell lines
11/13/2007US7294505 Stable episomal vectors
11/13/2007US7294495 PR03580 polypeptides
11/13/2007US7294493 Contacting methacrylonitrile, under suitable reaction conditions, with a catalyst having nitrile hydratase activity from Comamonas testosteroni 5-MGAM-4D
11/13/2007US7294485 Rat calcium channel subunits and related probes, cell lines and methods
11/13/2007US7294484 Production of polypeptides
11/13/2007US7294483 Culturing E. coli cells comprising a nucleic acid encoding the polypeptide in a culture medium while feeding to the culture medium a transportable organophosphate that is a sugar phosphate or a glycerophosphate, such that the nucleic acid is expressed, recovering the polypeptide from the cells
11/13/2007US7294482 Nucleotide sequences coding epidermal growth factor-like variant in skin-1, 2, and 3 (ELVIS); antitumor/wound healing agents; drug screening; treating skin disorders
11/13/2007US7294481 Method for producing recombinant proteins
11/13/2007US7294477 Allergen and treatment
11/13/2007US7294473 Methods of identifying substances that interact with JTT-1 protein
11/13/2007US7294335 PRO19645 antibodies
11/13/2007CA2318398C Novel peptides having biological activity
11/13/2007CA2006813C Purified ciliary neurotrophic factor
11/09/2007CA2547136A1 Novel strain of pseudomonas aeruginosa and related therapeutic components
11/08/2007WO2007127487A2 Materials and methods for reducing inflammation by inhibition of the atrial natriuretic peptide receptor
11/08/2007WO2007126850A2 Photoperiodic control of floret differentiation and yield in plants
11/08/2007WO2007126849A1 Cyclic hexadepsipeptides, processes for their production and their use as pharmaceuticals
11/08/2007WO2007126787A2 Reagents and methods for cancer treatment and prevention
11/08/2007WO2007126160A1 Prostasin partial peptide and anti-prostasin antibody
11/08/2007WO2007125982A1 Novel cultured silkworm cell enabling highly efficient baculovirus production and protein production
11/08/2007WO2007125940A1 Polypeptide derived from adult cat flea
11/08/2007WO2007056524A3 St3gal-1/st6galnac-1 chimeras
11/08/2007WO2007031559A3 Human coagulation factor vii polypeptides
11/08/2007WO2007016614A3 Control of sorbose utilization genes and uses thereof
11/08/2007WO2007004876A3 Peptides inhibiting angiotensin-converting enzyme
11/08/2007WO2006116763A3 Lawsonia intracellularis immunological proteins
11/08/2007US20070261135 Disease resistance factors
11/08/2007US20070260045 vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides
11/08/2007US20070259816 Expression vector comprising nucleotide sequences coding homeobox gene for use in identifying modulators for treatment and prevention of nervous system and seizure disorders
11/08/2007US20070259815 Albumin fusion proteins
11/08/2007US20070259422 isolated nucleic acid encoding an immunogenic peptide recognized by T lymphocytes; host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/08/2007US20070259414 Genetic engineering; fusion protein; kits comprising a recombinant vector containing a nucleic acid sequence encoding a UBL molecule selected from the group of SUMO, RUB, HUB, URM1, and ISG15 operably linked to a promoter suitable for expression in the desired host cell
11/08/2007US20070259406 Antimicrobial Compounds
11/08/2007US20070259405 Nucleic acid molecule that is codon-optimized to express beta interferon in Escherichia coli with greater efficacy
11/08/2007US20070259404 Method of Producing Heterologous Proteases
11/08/2007US20070259402 eukaryotic cell containing a first expression vector encoding a proprotein of Factor IX (proFIX), or a fusion protein of proFIX, and a second expression vector encoding a functional polypeptide PC5; precursor polypeptide for a Factor IX-Fc monomer-dimer hybrid; culturing
11/08/2007US20070259401 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules
11/08/2007US20070259400 Antibodies
11/08/2007US20070259398 Microwave Assisted Deglycosylation of Proteins for Molecular Weight Determination by Mass Spectrometry
11/08/2007US20070259387 Monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof
11/08/2007US20070259383 Novel Genes involved in Epidermal differentiation, and uses thereof
11/08/2007US20070259379 Regulation of glucose and insulin levels by gnt-4 glycosyltransferase activity
11/08/2007US20070259372 Melanoma differentiation associated gene - 5 and promoter and uses thereof
11/08/2007US20070259003 Clostridial toxin derivatives and methods for treating pain
11/08/2007US20070258992 Clostridial peptide for preventing or reducing immunoresistance to botulinum toxin therapy in humans and/or other mammals
11/08/2007US20070258978 Immunogenic Recombinant Antibody
11/08/2007US20070258962 Plasmid comprising murine cytomegalovirus intermediate early 2 (mCMV-IE2) promoter for enhancing heterologous gene transcription; gene therapy and genetic engineering
11/08/2007US20070258955 Lactobacillus acidophillus nucleic acid sequences encoding cell surface protein homologues and uses therefore
11/08/2007US20070258944 Multiple cytokine protein complexes
11/08/2007US20070258914 casein-derived peptides obtained by hydrolysis of casein by a food grade bacteria containing Lactobacillus helveticusto provide a fermented dairy product containing metalloproteinases inhibitory agent
11/08/2007US20070258895 Estrogen Receptors and Methods of Use
11/08/2007CA2650594A1 Adipose derived adult stem cells in hepatic regeneration
11/07/2007EP1852508A2 Actinomycetes polynucleotides
11/07/2007EP1852505A1 Mutations in ion channels
11/07/2007EP1851338A2 Multi-component inhibitors of nucleic acid polymerases
11/07/2007EP1851324A2 Novel proteins with enhanced functionality and methods of making novel proteins using circular permutation
11/07/2007EP1851323A1 Blood pressure lowering peptides from glycomacropeptide
11/07/2007EP1851305A1 Production of a polypeptide in a serum-free cell culture liquid containing plant protein hydrolysate
11/07/2007EP1851244A1 An anti-cd137 antibody as an agent in the treatement of cancer and glycosylation variants thereof
11/07/2007EP1851237A2 Pharmaceutical compositions for treating or preventing bone conditions
11/07/2007EP1534311B1 Method for identifying modulators of ion channels
11/07/2007EP1490394B1 Method and apparatus for the identification and qualification of biomolecules